The Eureka Moment

🧬 The Eureka Moment

Over the last three decades we have achieved some unique official milestones using IgY antibodies: like the World’s first registration of an oral antibody to prevent diarrhea in neonatal pigs and our phase 2 clinical trial to treat C. Difficile Infection in humans.

But over that same period we did some other experimenting with our antibodies, remembering it’s simply whole egg powder containing non-systemic antibody proteins. So other than possible egg allergy we weren’t concerned about safety.

Because the bacteria that causes diarrhea in pigs is the most common cause of human Travelers Diarrhea, this was our initial target. And we’ve had many unofficial successes with traveling friends, including my own personal food poisoning experience.

I truly wasn’t worried about safety but was concerned if someone we gave the egg powder to started taking it every day. So I became the guinea pig and started taking it every day. I like eggs and if nothing else I’m getting all their nutritional benefits.

For a period of some ten years to this point I had been experiencing chronic pain in my knees and shoulders. I had just had an MRI on my right shoulder and the diagnosis was severe osteoarthritis, which I’d guessed as I had limited mobility due to pain.

This diagnosis was at the same time as I was doing my daily experiment with our diarrhea egg antibodies. By the time I got into see the joint doctor about 25 days in, my pain had completely disappeared. That was a morning to remember and no pain since.

So now I’m pretty freaked out as I had been living with the arthritis pain for a long time and the only thing I’d done differently was taking the antibody egg every day. I naturally began Googling the possible association of gut health and arthritis. Lots of research and evidence. Maybe I’d landed on something by accident, which wouldn’t be the first time for a medical breakthrough as that’s how antibiotics were discovered.

Next strange occurrence, our lab tech with acid reflux came to me looking for a company benefits package. We’re a small company where group plans don’t work. I might as well just pay for her meds directly. Unfortunately we were also a small broke company so I suggested she try the same antibody I’d been using. My thought being acid reflux may also be gut related. Sure enough in a few weeks she reported her acid reflux gone and off the PPI meds. I told her to keep taking the egg powder everyday as we didn’t know the mechanism of action so why not continue to make sure it didn’t come back.

Unbeknownst to me, this same employee was also a severe asthmatic, typically spending one night a week at the local emergency ward. While she continued taking our antibody, within a couple more weeks she reported the end of her asthma symptoms and now hasn’t used her inhalers for over five years.

We’ve continued our unofficial experimenting and witnessed other interesting findings, like eczema and IBS improvements. Even athletes' foot improvements.

That’s a lot of changes to be written off solely as coincidence.

The idea that poor health often begins in the gut is more than two thousand years old. What has been missing is a specific mechanism that could connect traveler’s diarrhea, joint pain, asthma, acid reflux, and, potentially, heart disease, cancer and other chronic conditions.

Inside the gut lumen is a vast microbial ecosystem called the gut microbiome, made up of a couple thousand different species of trillions of small microbes. This conglomeration is separated from the bloodstream by a very thin barrier. Could a common thread in the gut microbiome leak into the bloodstream, travel to other organs and cause various health complications?

The organism that first made this visible in our work was ETEC bacteria.

🦠 What ETEC Does

ETEC is best known as a cause of diarrhea in neonatal pigs and of traveler’s diarrhea in people. An IgY antibody against it became the first veterinary medicine of its kind registered to prevent diarrhea in baby pigs. The same antibody later eased diarrhea in people with traveler’s diarrhea. After that, the same intervention was associated with relief of arthritis pain, improvement in asthma, resolution of acid reflux, and changes in other chronic complaints.

Those outcomes are hard to explain if ETEC only causes a short gut infection. They are easier to explain if ETEC does two other things.

First, ETEC secretes enterotoxins (heat-labile and heat-stable) that loosen the tight junctions of the intestinal lining. Permeability rises. Second, like other Gram-negative bacteria, ETEC carries lipopolysaccharide (LPS), an outer-membrane endotoxin. Once the junctions are opened, LPS that should remain in the lumen can cross into the blood.

The result is a double hit: enterotoxins open the door, and endotoxin walks through it. In the blood, even a low, ongoing leak is metabolic endotoxemia — a slow drip of inflammatory fuel. Most people never know it is happening.

šŸ”„ Why One Leak Could Look Like Many Diseases

If circulating LPS is the downstream problem, different organs can fail in different ways from the same source. This is a hypothesis, not a completed proof. It is the reading that best fits the pattern.

  • ā¤ļø Heart disease. LPS binds Toll-like receptor 4 on vessel walls, injures endothelium, favors oxidized LDL accumulation, and can accelerate and destabilize atherosclerotic plaque. An ETEC-driven LPS leak would not be the only cause of heart disease. It could be one continuous inflammatory input.
  • šŸŽ—ļø Cancer. Chronic inflammation and oxidative stress are established contributors to DNA damage and to a tissue environment in which abnormal cells survive and spread. Persistent LPS would be one such driver — an influence on progression, not a claim that ETEC is ā€œthe cause of cancer.ā€
  • 🧠 Mood. LPS can cross a compromised blood–brain barrier, activate microglia, disturb the HPA axis, and shift serotonin and dopamine signaling. In animal models, small endotoxin exposures produce withdrawal, low mood, and anxiety. The gut–brain complaints would then be downstream of the same leak.
  • 🦓 Joints. LPS engaging TLR4 in joint tissue activates macrophages, promotes cartilage breakdown, and sustains swelling. Arthritis pain that eases when the gut burden drops fits a fuel being removed, not a joint drug being added.
  • 🫁 Airways. Gut and lung share a mucosal immune network. Systemic LPS can prime T cells and mast cells so airways overreact to ordinary triggers. Fewer flares after the gut load falls is what that model predicts.
  • šŸ›”ļø Immunity. An innate immune system spent clearing gut-derived LPS is less available for everyday viruses and bacteria. Removing the distraction is a reset, not a stimulant.
  • āš–ļø Weight and metabolism. Endotoxemia inflames fat and liver cells and interferes with insulin and leptin signaling. Restoring sensitivity would show up as better glucose handling and loss of inflammatory weight.
  • 🩺 Gut symptoms. Locally, ETEC toxins irritate enteric nerves, disturb motility, and slow gastric emptying. Pressure then pushes acid upward. Reflux and IBS-type symptoms can be the near-field version of the same infection.
  • ✨ Skin. When the gut barrier leaks, skin can become an overflow route. Circulating LPS driving T-cell and mast-cell responses appears outwardly as eczema and inflamed skin.

Diet, sleep, genetics, and other microbes still matter. The claim is narrower: ETEC and its toxins look like a shared, removable input across this list, and a plausible influence on heart disease and cancer.


šŸ›”ļø GUT FYX

GUT FYX is not framed as a treatment for each of those diseases. It is an oral antibody against ETEC — the organism at the start of the thread.

The name is the mechanism: it acts in the GUT; It is a Food-based delivery of specific yolk antibodies Y is the antibody symbol; X is the target, ETEC. It stays in the lumen. The antibody is too large to cross into the blood in any meaningful amount. What is not bound passes through.

By binding ETEC, it lowers the bacterial load that produces both the enterotoxins and the LPS endotoxin. Fewer enterotoxins means tight junctions can close. Less LPS produced, and less LPS leaking, means the systemic drip slows. One target. The downstream effects, if the hypothesis is right, belong to the body once that provocation drops.

The same antibody class already has a veterinary biologic registration for ETEC diarrhea in neonatal pigs, and the active profile sits inside Chemistry, Manufacturing, and Controls used for ongoing human Phase 2 work. As a dietary food it can be offered for gut support and traveler’s defense while a separate biologic path for traveler’s diarrhea continues.

Because production is egg-based rather than cell-culture monoclonal, cost can stay in out-of-pocket range instead of specialty-drug pricing.


šŸŽÆ The Bottom Line

The gut lining is the gateway. When ETEC opens it and LPS follows, many diseases can look separate while sharing one upstream thread. GUT FYX is a way of reducing that ETEC burden at the source.

How One Bacterium Leaks Into Your Blood and Causes Chronic Disease